Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with sepsis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amikacin (amikacin)
  • Gentamicin (gentamicin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Sepsis | Phase 4 | Status: COMPLETED